Moderate-to-severe Ulcerative Colitis: Clinical Trials

1 trial for Moderate-to-severe Ulcerative Colitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Not yet recruiting 1

Follow Moderate-to-severe Ulcerative Colitis: new trials by email Literature Review of Moderate-to-severe Ulcerative Colitis trials Research Report on Moderate-to-severe Ulcerative Colitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease
RD06-05 CART Cell Infusion - Moderate-to-severe Ulcerative Colitis, Crohn's Disease (CD)
Early Phase 1Not yet recruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology302025-12-202025-12-30

Narrower conditions

Crohn Disease (1)

Broader conditions

Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Inflammatory Bowel Diseases (1)  ·  Intestinal Diseases (1)

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

China (1)

Top investigators

Xiaohua Hou, Prof. (1)